In article <20877 at blue.cis.pitt.edu>, jtrst4 at vms.cis.pitt.edu wrote:
> I've read that patients on GH therapy (non-recombinant) have
> had increased incidence if CJ. This has been attributed to
> the GH being infected with the virus. As we now have access
> to rhGH (recombinant human growth hormone) this is a moot
> point.
Iatrogenic transmission has also been reported for:
GH therapy
corneal transplants
mata dura grafts
etc...
Martin
--
..... Martin Leach Email:leach at mbcrr.harvard.edu
_|____ Dept. of Pharmacology Phone: (617) 638-5323
/ o / Boston Univ. School of Med. Fax: (617) 638-4329
_/ |-/__==/ 80 E. Concord St. (L603)
(BULLDOZER) \_ Boston MA 02118 "Not the old underpants on your
USA head.....WIBBLE" -BLACKADDER
p.s. try BioMOO (virtual biology on the internet - telnet
bioinfo.weizmann.ac.il 8888)